IMULAN BioTherapeutics, LLC is a company developing new therapeutics for atopic dermatitis in dogs (skin allergies, allergic dermatitis), feline stomatitis (lymphocytic plasmacytic stomatitis, gingivostomatitis), and infectious diseases (FeLV, FIV, etc.).  IMULAN technologies target central regulators of immunity, thereby permitting a comprehensive approach to disease intervention.  We are in late stage development of a new canine atopy treatment and several other diseases are also being investigated using our peptide technologies.  Visit our new website CanineAtopicDermatitis to learn more about our Atopic Dermatitis Treatment study for dogs.